Literature DB >> 34977994

Effect and associated factors of a clinical pharmacy model in the incidence of medication errors in the hospital Pablo Tobón Uribe eacpharmodel study: stepped wedge randomized controlled Trial (NCT03338725).

Johan Granados1,2, Pedro Amariles3, Juan Pablo Botero-Aguirre4, Natalia Andrea Ortiz-Cano4, Andrés-Felipe Valencia-Quintero3,4, Andrea Salazar-Ospina3,5.   

Abstract

Background The World Health Organization considers medication errors to be an issue that requires attention at all levels of care, to reduce the severe and preventable harm related to drug therapy. Different standards for clinical pharmaceutical practices have been proposed by various organizations across the world, where the pharmacist, as part of the multidisciplinary health team, can help improve patient safety. Objective To assess the impact of the introduction of a clinical pharmacy practice model on medication error in patients of a university hospital. Setting The study was conducted in a tertiary care hospital, Medellín, Colombia. Methods A randomized, controlled cluster-wedge staggered trial with a duration of 14 months was conducted to compare the clinical pharmacy practice model with the usual care process in the hospital. Five hospital health care units were included, which were initially assigned to the control group, and after an observation period of 2 months, they were randomly assigned to the intervention group. The trial protocol was registered in ClinicalTrials.gov (identifier NCT03338725). Main outcome measure The incidence of medication errors in hospitalized patients was the main outcome measure. Results The incidence of medication error was 13.3% and 22.8% for the intervention group and control group, respectively. The probability of presenting a medication error was 48% lower when the patient was in the intervention group (RR 0.52; 95% CI: 0.34-0.79). The probability of presenting a medication error over time was 44% lower in the intervention group (p = 0.0005); meanwhile, the resolution of a medication error over time was 70% higher in the intervention group (p = 0. 0029). Conclusion The clinical pharmacy practice model, made up of strategies focused on reducing medication errors, significantly reduces medication errors in patients during hospitalization compared with usual practice. This work assessed the effect of a clinical pharmacy model on the incidence of medication errors and demonstrated its effectiveness in reducing these errors in hospitalized patients. Trial registration ClinicalTrials.gov, NCT03338725. Registered on 9 November 2017. First patient randomized on February 2, 2018.
© 2021. The Author(s), under exclusive licence to Springer Nature Switzerland AG.

Entities:  

Keywords:  Medication error; Model; Pharmacist

Mesh:

Year:  2022        PMID: 34977994     DOI: 10.1007/s11096-021-01361-9

Source DB:  PubMed          Journal:  Int J Clin Pharm


  27 in total

1.  Clinical pharmacy services, hospital pharmacy staffing, and medication errors in United States hospitals.

Authors:  C A Bond; Cynthia L Raehl; Todd Franke
Journal:  Pharmacotherapy       Date:  2002-02       Impact factor: 4.705

2.  Implementation of a standard pharmacy clinical practice model in a multihospital system.

Authors:  Steven G Pickette; Lance Muncey; Danielle Wham
Journal:  Am J Health Syst Pharm       Date:  2010-05-01       Impact factor: 2.637

3.  Three signals from the Pharmacy Practice Model Summit.

Authors:  William A Zellmer; Daniel J Cobaugh; David Chen
Journal:  Am J Health Syst Pharm       Date:  2011-06-15       Impact factor: 2.637

4.  Ensuring consistent reporting of clinical pharmacy services to enhance reproducibility in practice: an improved version of DEPICT.

Authors:  Inajara Rotta; Teresa M Salgado; Daniel C Felix; Thais T Souza; Cassyano J Correr; Fernando Fernandez-Llimos
Journal:  J Eval Clin Pract       Date:  2015-02-12       Impact factor: 2.431

Review 5.  Economic evaluations of clinical pharmacist interventions on hospital inpatients: a systematic review of recent literature.

Authors:  James Gallagher; Suzanne McCarthy; Stephen Byrne
Journal:  Int J Clin Pharm       Date:  2014-09-14

6.  Drug-related morbidity and mortality. A cost-of-illness model.

Authors:  J A Johnson; J L Bootman
Journal:  Arch Intern Med       Date:  1995-10-09

7.  [Incident study of medication errors in drug use processes: prescription, transcription, validation, preparation, dispensing and administering in the hospital environment].

Authors:  Lourdes Pastó-Cardona; C Masuet-Aumatell; B Bara-Oliván; I Castro-Cels; A Clopés-Estela; F Pàez-Vives; J A Schönenberger-Arnaiz; M Q Gorgas-Torner; C Codina-Jané
Journal:  Farm Hosp       Date:  2009 Sep-Oct

8.  Effect of an In-Hospital Multifaceted Clinical Pharmacist Intervention on the Risk of Readmission: A Randomized Clinical Trial.

Authors:  Lene Vestergaard Ravn-Nielsen; Marie-Louise Duckert; Mia Lolk Lund; Jolene Pilegaard Henriksen; Michelle Lyndgaard Nielsen; Christina Skovsende Eriksen; Thomas Croft Buck; Anton Pottegård; Morten Rix Hansen; Jesper Hallas
Journal:  JAMA Intern Med       Date:  2018-03-01       Impact factor: 21.873

9.  Impact of collaborative pharmaceutical care on in-patients' medication safety: study protocol for a stepped wedge cluster randomized trial (MEDREV study).

Authors:  Géraldine Leguelinel-Blache; Christel Castelli; Clarisse Roux-Marson; Sophie Bouvet; Sandrine Andrieu; Philippe Cestac; Rémy Collomp; Paul Landais; Bertrice Loulière; Christelle Mouchoux; Rémi Varin; Benoit Allenet; Pierrick Bedouch; Jean-Marie Kinowski
Journal:  Trials       Date:  2018-01-08       Impact factor: 2.279

10.  Effect and associated factors of a clinical pharmacy model in the incidence of medication errors (EACPharModel) in the Hospital Pablo Tobón Uribe: study protocol for a stepped wedge randomized controlled trial (NCT03338725).

Authors:  J Granados; A Salazar-Ospina; J P Botero-Aguirre; A F Valencia-Quintero; N Ortiz; P Amariles
Journal:  Trials       Date:  2020-01-06       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.